Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2 (TANC2) is a large, multi-domain scaffold protein predominantly localized to the postsynaptic density of excitatory neurons[1][2][3][5][6]. It contains conserved domains (ankyrin repeats, tetratricopeptide repeats, and a coiled-coil region), as well as a predicted N-terminal ATPase domain unique to TANC2[3]. TANC2 organizes multi-protein complexes at glutamatergic synapses, facilitating the recruitment of dense core vesicles and modulating synaptic strength and plasticity[2][5][6]. It regulates dendritic spine development and morphology and acts as an adaptor protein inhibiting mTORC1/mTORC2 signaling, with a critical role in synaptic and neuronal development[1][6]. Mutations in TANC2 are strongly associated with a spectrum of neurodevelopmental and psychiatric disorders, including intellectual disability, autism, language delay, and schizophrenia[1][3][5]. Amplification of TANC2 has also been observed as an oncogenic driver in breast cancer, promoting proliferation and survival[1]. The protein's therapeutic targeting potential is being investigated, but approved drugs are not available[6].
Not drug-established; molecularly, modulation of mTORC1/mTORC2 signaling and synaptic function via protein-protein interactions Potential mechanism for future drugs: inhibition/restoration of TANC2-mediated signaling and scaffold assembly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat, ankyrin repeat and coiled-coil domain-containing protein 2 (TANC2).